Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman 被引量：2

Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman

下载PDF

导出

摘要 A 44-year-old woman developed jaundice and was diagnosed as stage Ⅱ of primary biliary cirrhosis(PBC).She showed a severely high total cholesterol level.This article focuses on atypical presentations of PBC and the need to test the total cholesterol level of PBC patients. A 44-year-old woman developed jaundice and was diagnosed as stage II of primary biliary cirrhosis (PBC). She showed a severely high total cholesterol level. This article focuses on atypical presentations of PBC and the need to test the total cholesterol level of PBC patients.

作者 Tatsuo Kanda Osamu Yokosuka Hiroshige Kojima Fumio Imazeki Keiich Nagao Ichiro Tatsuno Yasushi Saito Hiromitsu Saisho

机构地区 First Department of Medicine Health Sciences Center Second Department of Medicine

出处《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第17期2607-2608,共2页 世界胃肠病学杂志（英文版）

关键词 ADULT CHOLESTEROL Female Humans HYPERCHOLESTEROLEMIA Japan Liver Cirrhosis Biliary Severity of Illness Index 血胆脂醇过多胆汁胆硬化日本妇女消化系统

分类号 R589.2 [医药卫生—内分泌] R575.2 [医药卫生—内科学]

引文网络
相关文献

参考文献10

1Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61. 被引量：1
2Jahn CE, Schaefer EJ, Taam LA, Hoofnagle JH, Lindgren FT,Albers JJ, Jones EA, Brewer HB Jr. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology 1985; 89:1266-1278. 被引量：1
3Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM,Murtaugh PA, Dickson ER. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992; 15:858-862. 被引量：1
4Nikkila K, Hockerstedt K, Miettinen TA. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation.Hepatology 1991; 13:663-669. 被引量：1
5Seidel D, Alaupovic P, Furman RH, McConathy WJ. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest 1970; 49:2396-2407. 被引量：1
6Ganotakis ES, Mandalaki K, Tampakaki M, Malliaraki N,Mandalakis E, Vrentzos G, Melissas J, Castanas E. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy. Angiology 2003; 54:569-576. 被引量：1
7Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, Dore CJ, Finer N, Naoumova P. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002; 112:348-354. 被引量：1
8Longo M, Crosignani A, Battezzati PM, Squarcia Giussani C,Invemizzi P, Zuin M, Podda M. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002; 51:265-269. 被引量：1
9Chauhan SS, Zucker SD. Hypercholesterolemia in primary biliary cirrhosis: getting to the heart of the matter? Gastroenterology 2003; 124:854-856. 被引量：1
10Kancla T, Yokosuka O, Imazeki F, Saisho H. Bezafibrate treatment:a new medical approach for PBC patients? J Gastroenterol 2003;38:573-578. 被引量：1

同被引文献9

1Roger Klein Moreira,Frank Revetta,Elizabeth Koehler,Mary Kay Washington.Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease[J].World Journal of Gastroenterology,2010,16(4):453-457. 被引量：11
2Fu-Kui Zhang, Ji-Dong Jia and Bao-En Wang Beijing, China Liver Research Center, Beijing Friendship Hospital, Capital University of Medical Sciences, Beijing 100050 , China.Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):288-291. 被引量：7
3Hiroaki Yokomori,Masaya Oda,Go Wakabayashi,Masaki Kitajima,Kazunori Yoshimura,Masahiko Nomura,Toshifumi Hibi.High expressions of caveolins on the proliferating bile ductules in primary biliary cirrhosis[J].World Journal of Gastroenterology,2005,11(24):3710-3713. 被引量：4
4Hiroaki Yokomori,Masaya Oda,Mariko Ogi,Go Wakabayashi,Shigeyuki Kawachi,Kazunori Yoshimura,Toshihiro Nagai,Masaki Kitajima,Masahiko Nomura,Toshifumi Hibi.Expression of adhesion molecules on mature cholangiocytes in canal of Hering and bile ductules in wedge biopsy samples of primary biliary cirrhosis[J].World Journal of Gastroenterology,2005,11(28):4382-4389. 被引量：4
5Elias Kouroumalis,George Notas.Pathogenesis of primary biliary cirrhosis: A unifying model[J].World Journal of Gastroenterology,2006,12(15):2320-2327. 被引量：10
6Giada Sebastiani,Alfredo Alberti.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy[J].World Journal of Gastroenterology,2006,12(23):3682-3694. 被引量：33
7顾而立,姚光弼.中国人原发性胆汁性肝硬化的临床特点：52年文献的系统分析[J].中华肝脏病杂志,2009,17(11):861-866. 被引量：44
8Xiao-HuaJiang,Ren-QianZhong,Sheng-QianYu,YinHu,Weng-WengLi,Xian-TaoKong.Construction and expression of a humanized M_2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis[J].World Journal of Gastroenterology,2003,9(6):1352-1355. 被引量：17
9KazufumiDohmen,ToshihikoMizuta,MakotoNakamuta,NaoyaShimohashi,HiromiIshibashi,KyosukeYamamoto.Fenofibrate for patients with asymptomatic primary biliary cirrhosis[J].World Journal of Gastroenterology,2004,10(6):894-898. 被引量：12

引证文献2

1Vasiliy Ivanovich Reshetnyak.Concept on the pathogenesis and treatment of primary biliarycirrhosis[J].World Journal of Gastroenterology,2006,12(45):7250-7262. 被引量：11
2Vasiliy Ivanovich Reshetnyak.Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis[J].World Journal of Gastroenterology,2015,21(25):7683-7708. 被引量：22

二级引证文献32

1王淇泓,周晔,王爱华,竺蓓,邓安梅,仲人前.IL-22在原发性胆汁性肝硬化中的表达及其临床意义[J].现代检验医学杂志,2010,25(1):25-27. 被引量：5
2黄元兰,陈燕,周晔,陈孙孝,邓安梅,仲人前.原发性胆汁性肝硬化患者中β-arrestin 1表达增高及其意义[J].现代检验医学杂志,2010,25(6):11-14.
3石运莹,史旭华,费允云,张烜,张奉春.熊去氧胆酸及其联合激素和免疫抑制剂治疗原发性胆汁性肝硬化的临床观察[J].中华风湿病学杂志,2011,15(2):91-96. 被引量：15
4刘晓,胡志德,邓安梅,仲人前.原发性胆汁性肝硬化患者单核细胞内miR-302e表达降低及意义[J].第二军医大学学报,2012,33(2):160-164. 被引量：2
5李卓敏,闫惠平.原发性胆汁性肝硬化T细胞免疫研究进展[J].北京医学,2013,35(12):1025-1028. 被引量：2
6彭桉平,陈曲波,侯敬侠,卢欣沂,赵蓉,赵莉.原发性胆汁性肝硬化患者外周血Th22细胞水平的变化及意义[J].实用医学杂志,2014,30(12):1987-1989. 被引量：3
7童晶晶,刘晓燕,陈婧,肖珑,杨昊臻,关崇丹,严立龙,胡瑾华.表达gp210抗体的原发性胆汁性肝硬化患者临床特点分析[J].胃肠病学和肝病学杂志,2016,25(6):666-668. 被引量：2
8王海霞,张彩彩,宋其双.原发性胆汁性肝硬化44例临床和免疫学及病理学特征分析[J].中国临床新医学,2016,9(10):876-879. 被引量：4
9戴娜,戴亚萍,龚玉华,张丽.原发性胆汁性胆管炎-乙型病毒性肝炎重叠综合征患者临床特征分析[J].现代医药卫生,2016,32(22):3426-3428.
10陈辰,刘一博,张玮.Th1/Th2与原发性胆汁性胆管炎相关性的研究进展[J].肝脏,2016,21(12):1077-1080. 被引量：5

1Meral ■en,A Ziya Anadol,Mehmet O■uz.Effect of hypercholesterolemia on experimental colonic anastomotic wound healing in rats[J].World Journal of Gastroenterology,2006,12(8):1225-1228. 被引量：1
2Zhi-jian Lin Bing Zhang Xiao-qing Liu Hong-lian Yang.Abdominal Fat Accumulation with Hyperuricemia and Hypercholesterolemia Quail Model Induced by High Fat Diet[J].Chinese Medical Sciences Journal,2009,24(3):191-194. 被引量：15
3韩善乐,张君利.自身免疫性肝病158例临床分析[J].中国医药科学,2012,2(24):42-44. 被引量：3
4杨永红,夏培君,张武.肝硬化与胆石症的关系探讨[J].山东医药,2001,41(14):11-12. 被引量：6
5An atypical presentation of a typical arrhythmia[J].心电与循环,2016,35(6):460-463.
6WU Chi-hong WANG Qin-huan TIAN Geng-shan XU Xiao-yuan YU Yan-yan WANG Gui-qiang.Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study[J].Chinese Medical Journal,2006(3):238-241. 被引量：7
7治高血压和血胆脂醇过多的Caduet将进入日本[J].中国新药杂志,2009,18(23):2235-2235.
8蔡海江.GENE THERAPY OF FAMILIAL HYPERCHOLESTEROLEMIA[J].Chinese Medical Journal,1996(2):8-10.
9孙丽梅,王一鹏,刘燕敏,赵艳,张欣,王熠,赵丹彤,张海萍,马胤雪,闫惠平.抗线粒体抗体M2亚型在非原发性胆汁性肝硬化患者中的特点[J].中华肝脏病杂志,2015,23(5):343-349. 被引量：14
10HongqiZhang AijunSun YingminZhang JianguoJia KeqiangWang JunboGe.Effects of hypercholesterolemia on the artery that is grafted into the vein in rabbit[J].中国组织化学与细胞化学杂志,2004,13(3):409-409.

World Journal of Gastroenterology

2004年第17期

浏览历史

内容加载中请稍等...

Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman 被引量：2

参考文献10

同被引文献9

引证文献2

二级引证文献32

相关作者

相关机构

相关主题

浏览历史